tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Relay Therapeutics reports Q3 EPS (43c), consensus (42c)
PremiumThe FlyRelay Therapeutics reports Q3 EPS (43c), consensus (42c)
2M ago
Relay Therapeutics Expands Board with New Appointments
Premium
Company Announcements
Relay Therapeutics Expands Board with New Appointments
2M ago
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy
Premium
Company Announcements
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy
4M ago
Relay Therapeutics Reports Q2 2025 Financial Results and Progress
PremiumCompany AnnouncementsRelay Therapeutics Reports Q2 2025 Financial Results and Progress
5M ago
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
Premium
The Fly
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
5M ago
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
Premium
Company Announcements
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
6M ago
Relay Therapeutics announces updated data for RLY-2608 with Fulvestrant
PremiumThe FlyRelay Therapeutics announces updated data for RLY-2608 with Fulvestrant
8M ago
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
Premium
The Fly
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
9M ago
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100